Company intelligence / Profile preview

Therapeutic Solutions International, Inc.

Elk City, Idaho, United Stateszoominfo.com ↗

Ownership: Private
Employees: ~3
Development stage: Commercial

Overview

TSOI has demonstrated preclinical and early clinical efficacy with its immune-modulatory agents. Its lead program JadiCell is in a Phase III trial for COVID-induced ARDS. The company has also filed patents on gene-silencing therapies and combination approaches using both exogenous stem cells and endogenous regenerative stimulation. Early data suggest potential benefit in oncology when combining their nutraceutical NanoStilbene with immunotherapy agents like Yervoy™.

Therapeutic areas: PulmonologyPsychiatryOncologyNeurology
Modalities: Mesenchymal stem cell therapyStem cell therapyInduced pluripotent stem cells (iPSC)Biological productsBispecific antibodiesSmall molecules/nutraceuticals (e.g., pterostilbene-based products)
Industry: Biotech

Drug pipeline

10 assets

JadiCell

9 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Therapeutic Solutions International, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Therapeutic Solutions International, Inc..

Explore the full profile